Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Comparative evaluation of Lu-177-HP2 and In-111-HP2, secondary agents for affibody-based PNA-mediated radionuclide pretargeting
KTH, School of Biotechnology (BIO), Protein Technology.ORCID iD: 0000-0003-4334-9360
Show others and affiliations
2016 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 43, p. S237-S237Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Springer, 2016. Vol. 43, p. S237-S237
National Category
Medical Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-201266ISI: 000391801600594OAI: oai:DiVA.org:kth-201266DiVA, id: diva2:1074271
Conference
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), OCT 15-19, 2016, Barcelona, SPAIN
Note

QC 20170215

Available from: 2017-02-15 Created: 2017-02-15 Last updated: 2017-11-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Westerlund, KristinaEriksson Karlström, Amelie

Search in DiVA

By author/editor
Westerlund, KristinaEriksson Karlström, Amelie
By organisation
Protein Technology
In the same journal
European Journal of Nuclear Medicine and Molecular Imaging
Medical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 60 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf